Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Nancy Reau Covers Alcohol Use Disorder Interventions to Prevent Alcoholic Hepatitis
November 19th 2022As patients come into clinic and receive appropriate follow-up, we can hopefully find ways to mitigate the increase in alcoholic hepatitis, said Nancy Reau, MD, section chief of hepatology at Rush University Medical Center.
Read More
JDRF's Tom Robinson Expands on Policies to Ensure Implementation, Access to Key T1D Interventions
November 19th 2022Get type 1 diabetes (T1D) communities involved in solving the problem and implementing T1D interventions in your country, said Tom Robinson, vice president of global access at JDRF.
Read More
JDRF's Tom Robinson Highlights Key T1D Interventions
November 16th 2022While each country has a different priority when it comes to type 1 diabetes (T1D) diagnosis and treatment, there is a fairly consistent outcomes checklist across nations, said Tom Robinson, vice president of global access at JDRF.
Read More
Stem Cell Transplant May Be Viable Treatment for Patients With HIV, Leukemia, Says Dr Jana Dickter
November 16th 2022Jana K. Dickter, MD, associate clinical professor, Division of Infectious Diseases, City of Hope, discusses a patient's experience being the oldest person to successfully undergo a stem cell transplant while living with HIV and leukemia.
Read More
OneOncology’s Clinical Pathways Covers Best Practices for 90% of Patients, Says Dr Ted Arrowsmith
November 13th 2022The disease groups that make up the OneOncology clinical pathways program cover 90% of patients with cancer and develop best practices for treating cancer in the majority of patients, said Edward “Ted” Arrowsmith, MD, MPH, managing partner and director of research, East Tennessee Division, Tennessee Oncology.
Read More
Dr Davey Daniel Hits the High Points of the OneOncology Annual Conference
November 12th 2022The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.
Read More
Dr Joseph Alvarnas Explains Barriers to Clinical Trial Diversity and Payer Participation
November 11th 2022For the US health care system to be appropriately patient-centered, clinical trials need to be reflective of the country's diversity, said Joseph Alvarnas, MD, vice president of government affairs and senior medical director for employer strategy at City of Hope.
Read More
Dr Debra Patt: DESTINY-Breast04 Realizes a Promise of Modern Cancer Therapy
November 11th 2022Debra Patt, MD, PhD, MBA, executive vice president of public policy and strategic initiatives at Texas Oncology, expands on her keynote address at the 2022 meeting of Patient-Centered Oncology Care®, which focused on DESTINY-Breast04 study findings and their applicability to managed care.
Read More
Dr Jeffrey Patton on Setting Standards of Care Through OneOncology’s Clinical Pathways Program
November 11th 2022Representatives across 12 disease groups make up a council that sets clinical recommendations for oncology care and those decisions are being pushed out in the electronic medical record for decision support at the point of care, said Jeffrey Patton, MD, CEO, OneOncology, and executive chairman of the board, Tennessee Oncology. Patton will lead off OneOncology's Physician Leadership Conference, which runs November 11-13 in Nashville.
Read More
Meet Dr Ishani Ganguli, Seema S. Sonnad Emerging Leader in Managed Care Research Award Recipient
November 10th 2022Ishani Ganguli, MD, MPH, assistant professor of medicine at Harvard Medical School, physician at Brigham and Women’s Hospital, reacts to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Read More
Dr Neil Iyengar Emphasizes Importance of Population Health Lens in Oncology at PCOC 2022
November 10th 2022Population health brings an important lens to both oncology practice and research, said Neil Iyengar, MD, associate attending physician, breast medical service, Memorial Sloan Kettering Cancer Center.
Read More
Provider Knowledge on Liver Disease Guidelines Varies, Dr Nancy Reau Says
November 8th 2022Nancy Reau, MD, section chief of hepatology at Rush University Medical Center, elaborates on survey results showing providers have varying awareness and understanding on guidelines for chronic liver disease.
Read More
Dr Kashyap Patel Talks Value-Based Care, Defining Value, Other Themes at PCOC 2022
November 8th 2022Kashyap Patel, MD, president of Community Oncology Alliance and chief executive officer of Carolina Blood and Cancer Care Associates, previews the Patient-Centered Oncology Care® (PCOC) 2022 meeting happening this week in Nashville, Tennessee.
Read More
Manufacturer, Payer Collaboration Is Needed for PDT Coverage, Says Kelly Price
November 7th 2022To try to get a prescription digital therapeutic (PDT) covered, manufacturers need to align the value of their product to the priority of the payer, said Kelly Price, US head of rare disease at HRA Pharma.
Read More
Bhavesh Shah Discusses Expanding Access for BCMA Bispecific Antibody
November 7th 2022Bhavesh Shah, RPh, BCOP, chief pharmacy officer and director of specialty and hematology/oncology pharmacy at Boston Medical Center, talks about what oncology agents in the pipeline he hopes to see become available.
Read More
Change in Smoking Status and Subsequent BMI Change Linked to NAFLD Risk
November 3rd 2022Across 4 types of smoking status groups, nonalcoholic fatty liver disease (NAFLD) risk significantly increased among participants who saw an increase in body mass index (BMI) and decreased among participants whose BMI went down.
Read More
New ICD-10 Code Aims to Provide More Insight Into Hepatic Encephalopathy
October 26th 2022In an interview, the section chief of hepatology at Rush University Medical Center discussed why the addition of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code K76.82 is necessary.
Read More
Dr Kevin Astle on the Pharmacist's Role in PrEP Accessibility, Adherence
October 25th 2022Pharmacists must take time to understand why patients are not adherent to HIV pre-exposure prophylaxis (PrEP) and what barriers exist, said Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDES, assistant professor at the University of South Florida Taneja College of Pharmacy.
Read More
Conference Coverage: QCCA, NCCN, AACR
October 21st 2022Selected coverage from the Quality Cancer Care Alliance (QCCA) Summer 2022 National Leadership Summit, the National Comprehensive Cancer Network (NCCN) Fall Policy Summit, and the American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.
Read More